These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477 [TBL] [Abstract][Full Text] [Related]
7. Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment. Burnett HF; Regier DA; Feldman BM; Miller FA; Ungar WJ Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1382-91. PubMed ID: 22504893 [TBL] [Abstract][Full Text] [Related]
8. Juvenile idiopathic arthritis: classification, clinical presentation and current treatments. Dannecker GE; Quartier P Horm Res; 2009 Nov; 72 Suppl 1():4-12. PubMed ID: 19940489 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500 [TBL] [Abstract][Full Text] [Related]